Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Zhang, Wei, Wang, Tongguang, Pei, Zhong, Miller, David S., Wu, Xuefei, Block, Michelle L., Wilson, Belinda, Zhang, Wanqin, Zhou, Yong, Hong, Jau-Shyong, Zhang, Jing·2005·The FASEB Journal

DOI 10.1096/fj.04-2751com

Cited by (999)

Items 601–700 of 999

Daphnetin attenuates microglial activation and proinflammatory factor production via multiple signaling pathways
Wenwen Yu, Huanhuan Wang, Hangjie Ying, Yingying Yu, Dandan Chen, Weihong Ge, Liyun Shi · 2014 · International Immunopharmacology
Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: Relevance to Parkinson’s disease
So Yeon Lee, Younghye Moon, Dong Hee Choi, Hyun Jin Choi, Onyou Hwang · 2006 · Neurobiology of Disease
Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson’s disease
Yun Su, Changhe Shi, Tai Wang, Chen Liu, Jing Yang, Shuyu Zhang, Liyuan Fan, Huimin Zheng, Xinwei Li, Haiyang Luo et al. · 2022 · Journal of Neurology
Phenotype of postural instability/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters
Li-Jun Zuo, Ying‐shan Piao, Li-Xia Li, Shuyang Yu, Peng Fei Guo, Yang Hu, Tenghong Lian, Ruidan Wang, Qiu-Jin Yu, Zhao Yang Jin et al. · 2017 · Scientific Reports
3,6’-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation
Chih-Tung Lin, D. Lecca, Ling-Yu Yang, Weiming Luo, M. Scerba, D. Tweedie, Pen-Sen Huang, Y. Jung, Dong Seok Kim, Chih-Hao Yang et al. · 2020 · eLife
Cerebral sterile inflammation in neurodegenerative diseases
Otani, Kento, Shichita, Takashi · 2020 · Inflammation and Regeneration
A mechanistic view on the neurotoxic effects of air pollution on central nervous system: risk for autism and neurodegenerative diseases
Sahreh Shabani · 2021 · Environmental Science and Pollution Research
Implication of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Its Inhibitors in Alzheimer’s Disease Murine Models
Leticia Guadalupe Fragoso Morales, José Correa‐Basurto, Martha Cecilia Rosales‐Hernández · 2021 · Antioxidants
Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not Always
W. R. Wayne Martin, John R. Younce, Meghan C. Campbell, Brad Alan Racette, Scott A. Norris, Mwiza Ushe, Susan R. Criswell, Albert A. Davis, Isabel Alfradique‐Dunham, Baijayanta Maiti et al. · 2022 · Annals of Neurology
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
Maamoon Saleh, Milica Marković, Katherine E. Olson, Howard Eliot Gendelman, Rodney Lee Mosley · 2022 · Journal of Parkinson s Disease
Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia
William Charles Kreisl, Ioline D. Henter, Robert B. Innis · 2017 · Advances in pharmacology
Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases
Falguni Baidya, Mariya Bohra, Aishika Datta, Deepaneeta Sarmah, Birva Shah, Priya Jagtap, Swapnil Raut, Ankan Sarkar, Upasna Singh, Kiran Kalia et al. · 2020 · Immunology
Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein
Na Li, Tessandra Stewart, Lifu Sheng, Min Yan Shi, Eugene M. Cilento, Yufeng Wu, Jau-Syong Hong, Jing Zhang · 2020 · Journal of Neuroinflammation
Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
Tingting Du, Le Wang, Weijin Liu, Guanyu Zhu, Ying‐Chuan Chen, Jianguo Zhang · 2021 · Frontiers in Aging Neuroscience
Extracellular alpha-synuclein: Sensors, receptors, and responses
Renato Domingues, Ricardo Sant’Anna, Anna Carolina Carvalho da Fonseca, Bruno Kaufmann Robbs, Débora Foguel, Tiago F. Outeiro · 2022 · Neurobiology of Disease
Glia-derived extracellular vesicles in parkinson’s disease.
Marchetti, Bianca, Leggio, Loredana, L’Episcopo, Francesca, Vivarelli, Silvia, Tirolo, Cataldo, Paternò, Greta, Giachino, Carmela, Caniglia, Salvatore, Serapide, Maria Francesca, Iraci, Nunzio · 2020 · Journal of Clinical Medicine
Toxicity of extracellular secreted alpha-synuclein: Its role in nitrosative stress and neurodegeneration
Anna Wilkaniec, Joanna Benigna Strosznajder, Agata Adamczyk · 2013 · Neurochemistry International
Toll-like receptor 4 signaling: A common biological mechanism of regimen-related toxicities
Hannah R. Wardill, Ysabella Z. A. Van Sebille, Kimberley A. Mander, Rachel J. Gibson, Richard M. Logan, Joanne M. Bowen, Stephen T. Sonis · 2014 · Cancer Treatment Reviews
Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity
Bin Xing, Tao Xin, Lingling Zhao, Randy L. Hunter, Yan Chen, Guoying Bing · 2010 · Journal of Neuroimmunology
The Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator ADX88178 Inhibits Inflammatory Responses in Primary Microglia
Ranjani Ponnazhagan, Ashley S. Harms, Aaron D. Thome, Asta Jurkuvenaite, Rocco G. Gogliotti, Colleen Marie Niswender, Peter Jeffrey Conn, David G. Standaert · 2016 · Journal of Neuroimmune Pharmacology
Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration
Itzia Jiménez-Ferrer, Michael A S Jewett, Ashmita Tontanahal, Marina Romero‐Ramos, Maria Swanberg · 2017 · Neurobiology of Disease
Comparative analysis of Parkinson's disease–associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons
Nicolas Giguère, Consiglia Pacelli, Caroline Saumure, Marie-Josée Bourque, Diana Matheoud, Daniel Lévesque, Ruth S. Slack, David S. Park, Louis‐Éric Trudeau · 2018 · Journal of Biological Chemistry
α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson’s Disease Pathogenesis
Laura M. Butkovich, Madelyn C. Houser, Malú G. Tansey · 2018 · Frontiers in Neuroscience
Neurological effects of glucocerebrosidase gene mutations
Stephen Mullin, Derralynn A. Hughes, Atul B Mehta, Anthony H.V. Schapira · 2018 · European Journal of Neurology
Regional transcriptional architecture of Parkinson’s disease pathogenesis and network spread
Benjamin S. Freeze, Sneha Pandya, Yashar Zeighami, Ashish Raj · 2019 · Brain
Glial cells in Parkinson´s disease: protective or deleterious?
Ana Verónica Domingues, Inês Miguel Pereira, Helena Vilaça-Faria, António José Salgado, Ana João Rodrigues, Fábio Gabriel Teixeira · 2020 · Cellular and Molecular Life Sciences
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
Yoo Jin Jung, David Tweedie, Michael T. Scerba, Dong Seok Kim, Maria Francesca Palmas, Augusta Pisanu, Anna Rosa Carta, Nigel H. Greig · 2021 · Frontiers in Neuroscience
MMP-3 secreted from endothelial cells of blood vessels after spinal cord injury activates microglia, leading to oligodendrocyte cell death.
J. Lee, H. Choi, T. Yune · 2015 · Neurobiology of Disease
Minimally Toxic Dose of Lipopolysaccharide and α-Synuclein Oligomer Elicit Synergistic Dopaminergic Neurodegeneration: Role and Mechanism of Microglial NOX2 Activation
Zhang, Wei, Gao, Jun-hua, Yan, Zhao-fen, Huang, Xi-yan, Guo, Peng, Sun, Li, Liu, Zhuo, Hu, Yang, Zuo, Li-jun, Yu, Shu-yang et al. · 2018 · Molecular Neurobiology
High-intensity interval training modulates inflammatory response in Parkinson’s disease
Paulina Malczynska-Sims, Małgorzata Chalimoniuk, Zbigniew Wroński, Jarosław Marusiak, Anna Sułek · 2022 · Aging Clinical and Experimental Research
The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease
Daniele Caligiore, Flora Giocondo, Massimo Silvetti · 2022 · IBRO Neuroscience Reports
The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease
Yongzhen Miao, Hongrui Meng · 2024 · Cell Communication and Signaling
Resveratrol as a Protective Molecule for Neuroinflammation: A Review of Mechanisms
Justine Renaud, Maria‐Grazia Martinoli · 2014 · Current Pharmaceutical Biotechnology
Review: Microglia in protein aggregation disorders: friend or foe?
Steve Gentleman · 2013 · Neuropathology and Applied Neurobiology
Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication for theranostics
Seong Soo A. An, Bong‐Hee Lee, Kyunghee Byun, Enkhjargal Bayarsaikhan, Delger Bayarsaikhan, Jaesuk Lee, Myeongjoo Son, Jeongsik Moon, Hye‐Jeong Park, Arivazhagan Roshini et al. · 2016 · International Journal of Nanomedicine
The effect of α-synuclein on gliosis and IL-1α, TNFα, IFNγ, TGFβ expression in murine brain
Anna Sznejder-Pachołek, Ilona Joniec‐Maciejak, Adriana Wawer, Agnieszka Ciesielska, Dagmara Maria Mirowska-Guzel · 2016 · Pharmacological Reports
Novel Targets for Parkinson’s Disease: Addressing Different Therapeutic Paradigms and Conundrums
Pallavi Rane, Deepaneeta Sarmah, Shashikala Bhute, Harpreet Kaur, Avirag Goswami, Kiran Kalia, Anupom Borah, Kunjan R. Dave, Nutan Sharma, Pallab Bhattacharya · 2018 · ACS Chemical Neuroscience
Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson’s Disease
Songzhe He, Shan Zhong, Gang Liu, Jun Yang · 2020 · Neurodegenerative Diseases
Inflammatory Responses to Monomeric and Aggregated α-Synuclein in Peripheral Blood of Parkinson Disease Patients
Federica Piancone, Marina Saresella, Francesca La Rosa, Ivana Marventano, Mario Meloni, Jorge Navarro, Mario Clerici · 2021 · Frontiers in Neuroscience
Immune-related biomarkers for Parkinson's disease
Ilham Y. Abdi, Simona S. Ghanem, Omar M. A. El‐Agnaf · 2022 · Neurobiology of Disease
Reactive microgliosis participates in MPP + ‐induced dopaminergic neurodegeneration: role of 67 kDa laminin receptor
Tongguang Wang, Wei Zhang, Zhong Pei, Michelle L. Block, Belinda C. Wilson, Jeffrey M. Reece, David S. Miller, Jau‐Shyong Hong · 2006 · The FASEB Journal
Microalgae as a potential therapeutic drug candidate for neurodegenerative diseases
Royapuram Parthasarathy Parameswari, Lakshmi Prasanth Thangavelu · 2022 · Journal of Biotechnology
Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives
Wael M.Y. Mohamed, Jaya Kumar, Badrah Saeed Ali Alghamdi, Al-Hassan Soliman Wadan, Toshihide Yamashita · 2022 · IBRO Neuroscience Reports
Blood-brain Barrier and Neurovascular Unit Dysfunction in Parkinson's Disease: From Clinical Insights to Pathogenic Mechanisms and Novel Therapeutic Approaches
Sarah Lei Qi Khor, Khuen Yen Ng, Rhun Yian Koh, Soi Moi Chye · 2023 · CNS & Neurological Disorders - Drug Targets
A role for microglia in mediating the microbiota–gut–brain axis
Lily Keane, Gerard A. Clarke, John F. Cryan · 2025 · Nature reviews. Immunology
Fractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases
Nicole M. Desforges, Michaeline L. Hebron, Norah Khaled Algarzae, Irina Lonskaya, Charbel Moussa · 2012 · International Journal of Alzheimer s Disease
Anti-Inflammatory and Neuroprotective Effects of PGE2 EP4 Signaling in Models of Parkinson’s Disease
Suraj Pradhan, Kirstie J. Salinas, Alexis C. Garduno, Jenny U. Johansson, Qian Wang, Amy Manning-Bog, Katrin I. Andreasson · 2016 · Journal of Neuroimmune Pharmacology
Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies
Kwon, Somin, Iba, Michiyo, Masliah, Eliezer, Kim, Changyoun · 2019 · Experimental Neurobiology
Unilateral intranigral administration of β-sitosterol β-D-glucoside triggers pathological α-synuclein spreading and bilateral nigrostriatal dopaminergic neurodegeneration in the rat
Luis Oskar Soto-Rojas, Irma Alicia Martínez-Dávila, Claudia Luna-Herrera, María Eugenia Gutiérrez-Castillo, Francisco E. López-Salas, Bismark Gatica-García, Guadalupe Soto-Rodríguez, María Elena Bringas, Gonzalo Flores, América Padilla-Viveros et al. · 2020 · Acta Neuropathologica Communications
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Sheila K. Pirooznia, Liana S. Rosenthal, Valina Lynn Dawson, Ted M. Dawson · 2021 · Pharmacological Reviews
Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
Mohammad Badr, Rhonda L. McFleder, Jingjing Wu, Susanne Knörr, James B. Koprich, Thomas Hünig, Jonathan M. Brotchie, Jens Volkmann, Manfred Bernhard Lutz, Chi Wang Ip · 2022 · Journal of Neuroinflammation
Review of Amyotrophic Lateral Sclerosis, Parkinson’s and Alzheimer’s diseases helps further define pathology of the novel paradigm for Alzheimer’s with heavy metals as primary disease cause
Franco Cavaleri · 2015 · Medical Hypotheses
1-(5-bromo-2-hydroxy-4-methoxyphenyl)ethanone [SE1] suppresses pro-inflammatory responses by blocking NF-κB and MAPK signaling pathways in activated microglia
S.W.A. Himaya, BoMi Ryu, Zhong‐Ji Qian, Yong Li, Se‐Kwon Kim · 2011 · European Journal of Pharmacology
Regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by alpha-synuclein in rat primary glial cells
So Hyun Joo, Kyoung Ja Kwon, Ji‐Woon Kim, Joo Wan Kim, Mohammad Rakibul Hasan, He-Jin Lee, Seol‐Heui Han, Chan Young Shin · 2009 · Neuroscience Letters
Calcium Deregulation in Neurodegeneration and Neuroinflammation in Parkinson’s Disease: Role of Calcium-Storing Organelles and Sodium–Calcium Exchanger
Guendalina Bastioli, Silvia Piccirillo, Laura Graciotti, Marianna Carone, Giorgia Sprega, Omayema Taoussi, Alessandra Preziuso, Pasqualina Castaldo · 2024 · Cells
Cross‐linking for the analysis of α‐synuclein in the enteric nervous system
Anne-Gaëlle Corbillé, Michel Neunlist, Pascal Derkinderen · 2016 · Journal of Neurochemistry
The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson’s Disease
Giuseppina Mariucci, Rita Pagiotti, Francesco Galli, Luigina R. Romani, Carmela Conte · 2018 · Journal of Molecular Neuroscience
Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
Martin Kallab, Marcos Herrera-Vaquero, Malin Johannesson, Fredrik Eriksson, Jessica Sigvardson, Werner H Poewe, Gregor Karl Wenning, Eva K. L. Nordström, Nadia Stefanova · 2018 · Frontiers in Neuroscience
The degeneration of dopaminergic synapses in Parkinson's disease: A selective animal model
Ingrid Moráles, Alberto Sánchez, Clara Rodriguez‐Sabate, Manuel Rodrı́guez · 2015 · Behavioural Brain Research
Anti-inflammatory effects of a fluorovinyloxyacetamide compound KT-15087 in microglia cells
Jiyeon Ock, Sangseop Kim, Kyoungho Suk · 2009 · Pharmacological Research
Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology
Walker, Douglas G., Lue, Lih-Fen, Tang, Tiffany M., Adler, Charles H., Caviness, John N., Sabbagh, Marwan N., Serrano, Geidy E., Sue, Lucia I., Beach, Thomas G. · 2017 · Neurobiology of Aging
NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders
Yuri Zilberter, Dennis R. Tabuena, Misha Y. Zilberter · 2023 · Progress in Neurobiology
Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
Laura Boi, Augusta Pisanu, Maria Francesca Palmas, Giuliana Fusco, Ezio Carboni, Maria Antonietta Casu, Valentina Satta, María Scherma, Elżbieta Janda, Ignazia Mocci et al. · 2020 · International Journal of Molecular Sciences
Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases
Heather Wilson, Marios Politis, Eugenii A. Rabiner, Lefkos T. Middleton · 2020 · Cells
Inflammatory Mechanisms in Parkinson’s Disease: From Pathogenesis to Targeted Therapies
Stellina Y. H. Lee, Nathanael James Yates, Susannah J. Tye · 2021 · The Neuroscientist
Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
Gundersen, Vidar · 2021 · Frontiers in Neuroscience
Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration
Ernest James Phillips, Thomas, Maguire, Emily · 2021 · Frontiers in Cellular Neuroscience
Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress
Taylor J. Stevenson, Rebecca H. Johnson, Jimmy Savistchenko, Justin Rustenhoven, Zoe Woolf, Leon C. D. Smyth, Helen C. Murray, Richard L. M. Faull, Jason A. Correia, Patrick M. Schweder et al. · 2022 · Scientific Reports
α‐Synuclein induced cell death in mouse hippocampal (HT22) cells is mediated by nitric oxide‐dependent activation of caspase‐3
Agata Adamczyk, Anna Wilkaniec, Grzegorz Arkadiusz Czapski, Joanna Benigna Strosznajder · 2010 · FEBS Letters
Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation
David Tweedie, Kathryn A. Frankola, Weiming Luo, Yazhou Li, Nigel H. Greig · 2011 · The Open Biochemistry Journal
Challenges and Future Perspectives in Modeling Neurodegenerative Diseases Using Organ‐on‐a‐Chip Technology
Francesca Michela Pramotton, Sarah Spitz, Roger Dale Kamm · 2024 · Advanced Science
Neuroproteomics Approaches to Decipher Neuronal Regeneration and Degeneration
Faneng Sun, Valeria Cavalli · 2009 · Molecular & Cellular Proteomics
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity
Liudmila Mus, Francesca Siani, Claudio Giuliano, Christina Ghezzi, Silvia Cerri, Fabio Blandini · 2018 · Neurobiology of Disease
Nonpharmacological Modulation of Chronic Inflammation in Parkinson’s Disease: Role of Diet Interventions
Stefania Kalampokini, Anouck Becker, Klaus C Fassbender, Epameinondas Lyros, Marcus Michael Unger · 2019 · Parkinson s Disease
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
Lai, Thuy Thi, Kim, Yun Joong, Ma, Hyeo-il, Kim, Young Eun · 2022 · Journal of Movement Disorders
Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease
Sean Miller, Cameron E. Campbell, Helen A. Jimenez-Corea, Guanhui Wu, Robert A Logan · 2022 · Frontiers in Neuroscience
Cathepsin L-containing exosomes from α-synuclein-activated microglia induce neurotoxicity through the P2X7 receptor
Tianfang Jiang, Chuanying Xu, Shane Gao, Jia Zhang, Jia Zheng, Xiaolin Wu, Qiuyun Lu, Limei Cao, Danjing Yang, Jun Xu et al. · 2022 · npj Parkinson s Disease
Apoptosis signal-regulating kinase 1 modulates the phenotype of α-synuclein transgenic mice
Kang Woo Lee, Jong-Min Woo, Joo Young Im, Eun Su Park, Liqiang He, Hidenori Ichijo, Eunsung Junn, M. Maral Mouradian · 2014 · Neurobiology of Aging
Wogonin attenuates endotoxin‐induced prostaglandin E2 and nitric oxide production via Src‐ERK1/2‐NFκB pathway in BV‐2 microglial cells
Chung‐Hsin Yeh, Ming‐Ling Yang, Chien‐Ying Lee, Ching‐Ping Yang, Yi‐Ching Li, Chun‐Jung Chen, Yu‐Hsiang Kuan · 2013 · Environmental Toxicology
Parkinson's disease as a member of Prion-like disorders
María Eugenia Herva, Maria Grazia Spillantini · 2014 · Virus Research
The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications
Katarzyna Z. Kuter, Maria Angela Cenci, Anna Rosa Carta · 2020 · Progress in brain research
LRRK2-Related Parkinson’s Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A Hypothesis
Rivero-Ríos, Pilar, Romo-Lozano, María, Fasiczka, Rachel, Naaldijk, Yahaira, Hilfiker, Sabine · 2020 · Frontiers in Neuroscience
Chronic ethanol exposure induces neuroinflammation in H4 cells through TLR3 / NF-κB pathway and anxiety-like behavior in male C57BL/6 mice
Xiaolong Wang, Hao Qiang Yu, Changliang Wang, Yang Liu, Jiabin You, Pengfei Wang, Guohui Xu, Hui Shen, Hui Yao, Xinze Lan et al. · 2020 · Toxicology
Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson’s Disease Targeting Neuroinflammation
Chiung‐Mei Chen, Chien-Yu Yen, Wan-Ling Chen, Chih‐Hsin Lin, Yih‐Ru Wu, Kuo‐Hsuan Chang, Guey‐Jen Lee‐Chen · 2021 · International Journal of Molecular Sciences
The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
Yao Shen, Liyin Qian, Hu Luo, Xiaofang Li, Yuer Ruan, Runyue Fan, Zizhen Si, Yun-Peng Chen, Longhui Li, Yu Liu · 2022 · Brain Sciences
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients
Malin Wennström, Sara Hall, Katarina Nägga, Elisabet Londos, Lennart Minthon, Oskar Hansson · 2015 · Alzheimer s Research & Therapy
Strategic Selection of Neuroinflammatory Models in Parkinson's Disease: Evidence from Experimental Studies
Sandeep Vasant More, Hemant Kumar, In‐Su Kim, Sushruta Koppula, Byung-Wook Kim, Dong‐Kug Choi · 2013 · CNS & Neurological Disorders - Drug Targets
Glimepiride reduces CD14 expression and cytokine secretion from macrophages
Victoria Anne Ingham, Alun Williams, Clive Bate · 2014 · Journal of Neuroinflammation
Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems
Nicholas MacInnes, Mahmoud M. Iravani, Elaine King Perry, Margaret Ann Piggott, Robert Perry, Peter G. Jenner, Clive G. Ballard · 2008 · Journal of Neural Transmission
Heparin and Methionine Oxidation Promote the Formation of Apolipoprotein A-I Amyloid Comprising α-Helical and β-Sheet Structures
David J. Townsend, Eleri Hughes, Rohanah Hussain, Giuliano Siligardi, Sara J. Baldock, Jillian Madine, David A. Middleton · 2016 · Biochemistry
Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders
Navya Lakkappa, Praveen Thaggikuppe Krishnamurthy, Bruce D. Hammock, D. Velmurugan, M. M. Srinivas Bharath · 2016 · Medical Hypotheses
Caspases orchestrate microglia instrumental functions
Xianli Shen, Jose Luis Venero, Bertrand Joseph, Miguel Ángel Burguillos · 2018 · Progress in Neurobiology
Heterogeneity of Microglia Phenotypes: Developmental, Functional and Some Therapeutic Considerations
Yun Yuan, Chunyun Wu, Eng‐Ang Ling · 2019 · Current Pharmaceutical Design
The Role of Glial Mitochondria in α-Synuclein Toxicity
Yu‐Mi Jeon, Younghwi Kwon, Myungjin Jo, Shinrye Lee, Seyeon Kim, Hyung‐Jun Kim · 2020 · Frontiers in Cell and Developmental Biology
Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?
Panagiota Mavroeidi, Maria Vetsi, Dimitra Dionysopoulou, Maria Xilouri · 2022 · Biomolecules
Oxidative Stress, Neuroinflammation, and Neurodegeneration
Hui‐Ming Gao, Hui Zhou, Jau‐Shyong Hong · 2014 · Springer eBooks
An increase in voltage‐gated sodium channel current elicits microglial activation followed inflammatory responses in vitro and in vivo after spinal cord injury
Gil Y. Jung, Jee Y. Lee, Hyewhon Rhim, Tae H. Oh, Tae Young Yune · 2013 · Glia
New insights on Parkinson’s disease genes: the link between mitochondria impairment and neuroinflammation
Dorit Trudler, Yuval Nash, Dan Frenkel · 2015 · Journal of Neural Transmission
Curcumin as a potential therapeutic agent for treating neurodegenerative diseases
Valeria Perales-Salinas, Sushmitha S. Purushotham, Yossi Buskila · 2024 · Neurochemistry International
Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220
Ji Ae Lee, Hyo Jin Son, Jin‐Sung Choi, Jinwoo Kim, Se Hee Han, Nari Shin, Ji Hyun Kim, Soo‐Jeong Kim, Jun Young Heo, Dong Jin Kim et al. · 2017 · Neurochemistry International